Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-03-17 4:23 pm Unchanged | 13G | F-star Therapeutics Inc. FSTX | Beryl Capital Management LLC | 0 0.000% | 0 (Unchanged) | View |
| 2023-02-14 4:06 pm Unchanged | 13G | F-star Therapeutics Inc. FSTX | Ridgeback Capital Investments L.P. | 52,509 0.200% | 0 (Unchanged) | View |
| 2023-02-14 4:02 pm Sale | 13G | F-star Therapeutics Inc. FSTX | Ridgeback Capital Investments L.P. | 52,509 0.200% | -1,781,851 (-97.14%) | View |
| 2022-02-14 6:27 pm Sale | 13G | F-star Therapeutics Inc. FSTX | Rock Springs Capital Management LP | 751,889 3.650% | -302,343 (-28.68%) | View |
| 2022-02-14 4:45 pm Sale | 13G | F-star Therapeutics Inc. FSTX | Point72 Asset Management L.P. | 987,111 4.800% | -112,889 (-10.26%) | View |
| 2022-02-14 4:19 pm Sale | 13G | F-star Therapeutics Inc. FSTX | Boxer Capital LLC | 0 0.000% | -1,501,428 (Position Closed) | View |
| 2022-02-14 4:15 pm Purchase | 13G | F-star Therapeutics Inc. FSTX | Ridgeback Capital Investments L.P. | 1,834,360 8.900% | 1,340,000 (+271.06%) | View |
| 2022-02-11 5:42 pm Unchanged | 13G | F-star Therapeutics Inc. FSTX | Atlas Venture Opportunity Fund I L.P. | 599,524 2.900% | 0 (Unchanged) | View |
| 2022-02-10 4:50 pm Sale | 13G | F-star Therapeutics Inc. FSTX | GSK plc GSK | 802,627 3.900% | -1,295 (-0.16%) | View |
| 2022-02-08 5:00 pm Sale | 13G | F-star Therapeutics Inc. FSTX | Merck KGaA | 75,140 0.100% | -418,570 (-84.78%) | View |
| 2021-05-26 4:31 pm Unchanged | 13D | F-star Therapeutics Inc. FSTX | Cooperatieve AESCAP Venture I U.A. | 615,643 3.100% | 0 (Unchanged) | View |
| 2021-05-18 4:32 pm Purchase | 13G | F-star Therapeutics Inc. FSTX | Point72 Asset Management L.P. | 1,100,000 5.700% | 1,100,000 (New Position) | View |
| 2021-05-17 4:17 pm Purchase | 13G | F-star Therapeutics Inc. FSTX | Rock Springs Capital Management LP | 1,054,232 5.730% | 1,054,232 (New Position) | View |
| 2021-05-17 4:15 pm Purchase | 13G | F-star Therapeutics Inc. FSTX | Boxer Capital LLC | 1,501,428 8.200% | 1,501,428 (New Position) | View |
| 2021-04-09 4:54 pm Purchase | 13G | F-star Therapeutics Inc. FSTX | Ridgeback Capital Investments L.P. | 494,360 5.400% | 86,793 (+21.30%) | View |
| 2021-02-16 4:20 pm Purchase | 13G | F-star Therapeutics Inc. FSTX | Ridgeback Capital Investments L.P. | 407,567 4.500% | 407,567 (New Position) | View |
| 2021-02-12 8:17 pm Purchase | 13G | F-star Therapeutics Inc. FSTX | BIOTECHNOLOGY VALUE FUND L P | 25,844 1.000% | 25,844 (New Position) | View |
| 2021-02-03 5:20 pm Purchase | 13G | F-star Therapeutics Inc. FSTX | Atlas Venture Fund VII L P | 574,996 6.300% | 574,996 (New Position) | View |
| 2021-02-03 5:14 pm Purchase | 13G | F-star Therapeutics Inc. FSTX | Atlas Venture Opportunity Fund I L.P. | 599,524 6.600% | 599,524 (New Position) | View |
| 2021-02-01 4:32 pm Purchase | 13G | F-star Therapeutics Inc. FSTX | Merck KGaA | 493,710 5.400% | 493,710 (New Position) | View |